Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Azilsartan Medoxomil vs Valsartan and Olmesartan in Essential Hypertension
NCT00696436Phase 3Completed
- Sponsor
- Takeda
- Start
- Apr 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of azilsartan medoxomil in essential hypertension, sponsored by Takeda. Started Apr 2008; status: completed.
02
Drugs
azilsartan medoxomil
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00696436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00696436.